ContractInvestors’ Rights Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionEX-10.1 8 exhibit101s-1.htm EXHIBIT 10.1 Exhibit 10.1 GUARDANT HEALTH, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of the 9th day of May, 2017, by and among Guardant Health, Inc., a Delaware corporation (the “Company”) and the investors listed on Schedule A hereto, each of which is herein referred to as an “Investor” and collectively as the “Investors”. RECITALS WHEREAS, certain of the Investors (the “Existing Investors”) hold shares of the Company’s Series A Preferred Stock, par value $0.00001 per share, (the “Series A Preferred Stock”), the Company’s Series B Preferred Stock, par value $0.00001 per share, (the “Series B Preferred Stock”), the Company’s Series C Preferred Stock, par value $0.00001 per share, (the “Series C Preferred Stock”) and the Company’s Series D Preferred Stock, par value $0.00001 per share (the “Series D Preferred Stock”) and possess certain registration rights, informat
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • September 6th, 2018 • Guardant Health, Inc. • Services-medical laboratories • Delaware
Contract Type FiledSeptember 6th, 2018 Company Industry JurisdictionTHIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of the 9th day of May, 2017, by and among Guardant Health, Inc., a Delaware corporation (the “Company”) and the investors listed on Schedule A hereto, each of which is herein referred to as an “Investor” and collectively as the “Investors”.
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • July 5th, 2018 • Guardant Health, Inc. • Services-medical laboratories • Delaware
Contract Type FiledJuly 5th, 2018 Company Industry JurisdictionTHIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of the 9th day of May, 2017, by and among Guardant Health, Inc., a Delaware corporation (the “Company”) and the investors listed on Schedule A hereto, each of which is herein referred to as an “Investor” and collectively as the “Investors”.